Commonwealth Equity Services’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40K Buy
21,080
+3,830
+22% +$7.27K ﹤0.01% 4180
2025
Q1
$16K Buy
17,250
+1,000
+6% +$928 ﹤0.01% 4134
2024
Q4
$20K Buy
16,250
+3,625
+29% +$4.46K ﹤0.01% 4041
2024
Q3
$16K Buy
+12,625
New +$16K ﹤0.01% 4012